Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Clinical characteristics and treatment outcome of Acute lymphoblastic leukemia with the t(4;11)(q21;q23):A collaborative study of 40 cases. By Ching-Hon Pui, Lawrence S. Frankel, Andrew J. Carroll, Susana C. Raimondi, Jonathan J. Shuster, David R. Head, William M. Crist, Vita J. Land, D. Jeanette Pullen, C. Philip Steuber, Frederick G. Behm, and Michael J. Borowitz 1991.Blood; 77(3):440-447 Introduction The leukemias are agroup of disorders characterized by accumulation of malignant WBC in bone marrow and cells. The leukemia can classificate depend on how quickly the disease developes and get wores. Acute Lymphoblastic Chronic myeloid lymphoblastic myeloid Acute lymphoblastic leukemia(ALL) _It is rapid form of leukemia of the WBC characterized by exess unusually immature destined to become lymphocytes. ALL result from somatic mutation in DNA which activation of oncogen and inactivation of tumor suppressor gene . _There are deferent kinds of mutation happen in the DNA (DELETION,TRANSLOCATION,INVERSION). The mutation which occure in ALL is translocation. -specific chromosomal translocation convy important biologic and prognostic information in childhood leukemia , most of the cases have not undergone complet immunophenotypic characterization , thus the frequency of this chromosomal abnormality in childhood leukemia remain unclear. -t(4;11) strong associated with infant and the prognostic significance of this t. in other age group is unclear. The aim of the work -Describe the frequency clinical and laboratory features and treatment outcome for 40 children with ALL. By immunophenotype and chromosomal analysis. Material and Methds Subjects _The sample is leukemia cell from bone marrow from total of 1.986 patient. _1.986 patient successfully karyotyped cases represent 73% of all children(2.729). 1.986 patient 40 patient(20%) {25 girls and 15 boys} 515 admitted to total Therapy at SJCRH between1979-1989 1.471 enrolledin POG Methods (A) Morphology (B) Chromosomal analysisi (C) Immunophenotype (D) Statistic analysis (A)Morphology (B)Chromosomal analysis (1)Prepare the sample for karyotype Culture leukemia cell Metaphase arrest (2)Staining the slid with G-stain In karyotype (C)Immunophenotype -Get leukocytes by Ficoll-Hypaque Gradient. -using flow cytometey (D)Statistic analysis Result Discussion -In other studies CD24, B-lineage marker present in more than 95%of cases of B-pre-cell ALL, but in their studies CD24 was expressed in only B of 28 cases tested In other studies CD45 present in less than 5% of cases of B-pre-cell ALL, but in their studies CD45 expression was found in 20 of their 32 t(4;11)cases . Conclusion -Cases with the t(4;11)are associated with femal sex,very young age at presentation,hyperleukocytosis,the CD10/CD15+/CD19+/CD24-+ Immunophenotype, and poor treatment outcome for infants and patient aged >10years. Additional studies are clearly merited to determaine the independent prognostic significance of the t(4;11)and to assess possible molecular differences in this t. for different age groups.